Stem Cell Therapy for Demyelinating Disorders
Multiple sclerosis (MS) is a progressive disease of the central nervous system (CNS) that attacks mainly young people. It leads to the progressive deterioration of the neurological status. Histopatologically, this disease is characterized by appearance of multiple foci of the demyelination in white...
Main Authors: | Jan Pazour, Jaroslav Mokrý |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2006-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/49/2/0079/ |
Similar Items
-
PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination
by: Joshua C. Murtie, et al.
Published: (2005-06-01) -
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
by: Joel Gruchot, et al.
Published: (2019-08-01) -
Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
by: Jorge Matías-Guiu, et al.
Published: (2020-07-01) -
Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
by: H.C. Hoyos, et al.
Published: (2014-02-01) -
Adenosine Actions on Oligodendroglia and Myelination in Autism Spectrum Disorder
by: Hai-Ying Shen, et al.
Published: (2018-12-01)